Purpose-built for physicians GLP-1 use before weight-loss surgery rising, not linked to harmful outcomes Key takeaways: The use of GLP-1 receptor agonists in the year before weight-loss surgery rose more than threefold between 2018 and 2023
This route bypasses other common toxin exposure sites, including the lungs and GI tract
E.TengJ.FotopoulosM.RoumeliotisT
On the other hand, cardiovascular tissues react to GLP-1 via activated survival pathways, indicating possible protective benefits
Sleep Support+ GLP-1/GIP Contains Tirzepatide, NAD+, Vitamin B12, Magnesium, and L-Theanine Compounded oral blend of Tirzepatide, NAD+, Vitamin B12, Magnesium, and L-Theanine, formulated to help support relaxation, balanced metabolism, and restorative sleep patterns